Bath & Body Works (NYSE:BBWI) Stock Price Target Cut by Wells Fargo & Company

Bath & Body Works (NYSE:BBWI – Get Free Report) had its target price reduced by equities researchers at Wells Fargo & Company from $25.00 to $24.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 28.55% from the stock’s previous close.

A number of other research analysts have also weighed in on the stock. Morgan Stanley cut their price target on shares of Bath & Body Works from $22.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday. Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Wednesday, September 16th. UBS Group increased their price objective on shares of Bath & Body Works from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, November 13th. Robert W. Baird lowered their price objective on shares of Bath & Body Works from $23.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price objective on the stock in a report on Tuesday, August 18th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $22.00.

Read Our Latest Stock Report on BBWI

Bath & Body Works Price Performance

NYSE BBWI opened at $18.67 on Friday. The firm has a market cap of $3.76 billion, a P/E ratio of 5.10, a P/E/G ratio of 0.93 and a beta of 1.31. The stock’s 50-day moving average is $19.24 and its 200-day moving average is $19.75. Bath & Body Works has a one year low of $14.27 and a one year high of $24.94.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 57.47% and a net margin of 10.32%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the firm earned $0.37 EPS. Bath & Body Works’s quarterly revenue was down 1.1% compared to the same quarter last year. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Equities analysts anticipate that Bath & Body Works will post 2.77 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Allworth Financial LP increased its stake in Bath & Body Works by 3.1% during the 3rd quarter. Allworth Financial LP now owns 17,371 shares of the company’s stock valued at $277,000 after purchasing an additional 521 shares in the last quarter. Pathstone Holdings LLC raised its holdings in Bath & Body Works by 1.1% during the third quarter. Pathstone Holdings LLC now owns 52,031 shares of the company’s stock worth $828,000 after buying an additional 581 shares during the last quarter. Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after buying an additional 673 shares in the last quarter. Rothschild Investment LLC lifted its stake in shares of Bath & Body Works by 12.5% in the third quarter. Rothschild Investment LLC now owns 7,570 shares of the company’s stock valued at $121,000 after buying an additional 841 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Bath & Body Works by 40.7% during the second quarter. GAMMA Investing LLC now owns 5,050 shares of the company’s stock valued at $117,000 after buying an additional 1,460 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

More Bath & Body Works News

These are some of the BBWI news items that stood out recently:

  • Positive Sentiment: Third-quarter adjusted EPS of $0.26 topped the $0.12 consensus, while revenue of about $1.58 billion also exceeded estimates. Digital and wholesale gains helped offset weaker store performance. BBWI Q3 earnings beat estimates on digital and wholesale gains
  • Negative Sentiment: Q4 EPS guidance of $1.41–$1.61 came in below the $1.72 analyst consensus, with revenue guidance also below expectations at the midpoint. Reports of softer expected holiday sales add to concerns about near-term demand. Bath & Body Works trims FY26 EPS outlook
  • Negative Sentiment: Several firms lowered their BBWI price targets after the results, including UBS ($22 to $19), BMO ($24 to $20), and JPMorgan ($24 to $23). Most maintained neutral or equivalent ratings, signaling caution despite targets generally remaining above the recent share price. UBS Group rating and price target

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.